给明智之人的关于鼻内用艾氯胺酮的一句话。 - Suppr

A Word to the Wise About Intranasal Esketamine.

作者信息

Schatzberg Alan F

机构信息

Stanford University School of Medicine, Stanford, Calif.

出版信息

Am J Psychiatry. 2019 Jun 1;176(6):422-424. doi: 10.1176/appi.ajp.2019.19040423. Epub 2019 May 21.

DOI:10.1176/appi.ajp.2019.19040423

PMID:31109197

Abstract

摘要

相似文献

A Word to the Wise About Intranasal Esketamine.

Am J Psychiatry. 2019 Jun 1;176(6):422-424. doi: 10.1176/appi.ajp.2019.19040423. Epub 2019 May 21.

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.

CNS Drugs. 2021 Jul;35(7):781-794. doi: 10.1007/s40263-021-00826-9. Epub 2021 Jul 7.

In treatment-resistant depression, adding esketamine nasal spray to an oral antidepressant improved symptoms at 28 days.

Ann Intern Med. 2019 Sep 17;171(6):JC33. doi: 10.7326/ACPJ201909170-033.

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.

Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.

Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression.

Clin Pharmacokinet. 2021 Apr;60(4):501-516. doi: 10.1007/s40262-020-00953-4. Epub 2020 Oct 31.

Esketamine Nasal Spray for Treatment-Resistant Depression.

Nurs Womens Health. 2020 Jun;24(3):228-232. doi: 10.1016/j.nwh.2020.03.004. Epub 2020 May 6.

Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance.

World J Biol Psychiatry. 2021 Jul;22(6):468-482. doi: 10.1080/15622975.2020.1836399. Epub 2020 Nov 12.

Comment on a Word to the Wise About Intranasal Esketamine.

Am J Psychiatry. 2019 Oct 1;176(10):856-857. doi: 10.1176/appi.ajp.2019.19070688.

The Efficacy and Safety of Esketamine for the Treatment-Resistant Depression in Older Adults: Comments on TRANSFORM-3 Trial Results.

Am J Geriatr Psychiatry. 2020 Feb;28(2):142-144. doi: 10.1016/j.jagp.2019.10.009. Epub 2019 Oct 18.

Esketamine nasal spray (Spravato) for treatment-resistant depression.

Med Lett Drugs Ther. 2019 Apr 8;61(1569):54-57.

引用本文的文献

Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD).

Indian J Psychiatry. 2025 Jun;67(6):635-638. doi: 10.4103/indianjpsychiatry_315_25. Epub 2025 Jun 11.

Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee.

Ther Adv Drug Saf. 2025 Jun 19;16:20420986251347360. doi: 10.1177/20420986251347360. eCollection 2025.

Is there a risk of esketamine misuse in clinical practice?

Ther Adv Drug Saf. 2025 Jan 29;16:20420986241310685. doi: 10.1177/20420986241310685. eCollection 2025.

Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).

Adv Exp Med Biol. 2024;1456:49-66. doi: 10.1007/978-981-97-4402-2_3.

Glutamatergic Modulators for Major Depression from Theory to Clinical Use.

CNS Drugs. 2024 Nov;38(11):869-890. doi: 10.1007/s40263-024-01114-y. Epub 2024 Aug 16.

Comparing the adverse effects of ketamine and esketamine between genders using FAERS data.

Front Pharmacol. 2024 Jul 12;15:1329436. doi: 10.3389/fphar.2024.1329436. eCollection 2024.

Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database.

Front Pharmacol. 2024 Jun 14;15:1414703. doi: 10.3389/fphar.2024.1414703. eCollection 2024.

Effect of Acute Ketamine Treatment on Sympathetic Regulation Indexed by Electrodermal Activity in Adolescent Major Depression.

Pharmaceuticals (Basel). 2024 Mar 10;17(3):358. doi: 10.3390/ph17030358.

Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis.

Front Psychiatry. 2024 Mar 8;15:1346697. doi: 10.3389/fpsyt.2024.1346697. eCollection 2024.

Research advances in the clinical application of esketamine.

Ibrain. 2022 Mar 5;8(1):55-67. doi: 10.1002/ibra.12019. eCollection 2022 Spring.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A Word to the Wise About Intranasal Esketamine.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献